No Data
ARS Pharmaceuticals Insider Lowered Holding By 50% During Last Year
ARS Pharmaceuticals SPRY Approval; AN2 Therapeutics ANTX Phase 2 Data
Oppenheimer Sees Aquestive Benefitting From FDA Okay of Rival Drug
Catalyst Watch: Eyes on Walmart Earnings, the July CPI Print, and 13F Filings
Express News | ARS Pharmaceuticals: For People With Commercial Insurance Covering Neffy, Limiting Pay to $25 for Each Prescription of 2 Single-Use Neffy Devices
Express News | ARS Pharmaceuticals Says For Eligible Patients Without Insurance Coverage, Co Will Offer A Cash Price Of $199 For Two Doses Of Neffy Via BlinkRx